Mahoko Ikeda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Mahoko Ikeda has a total of 128 co-authors. Here are the top co-authors by number of shared publications:
Kyoji Moriya
Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan
12 shared publicationsShu Okugawa
The University of Tokyo Hospital, Department of Infectious Diseases, Tokyo, Japan
10 shared publicationsKoh Okamoto
Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
9 shared publications- Shu Okugawa
Department of Infectious Diseases, The University of Tokyo Hospital, Tokyo, Japan
9 shared publications Marie Yamashita
Department of Infectious Diseases, The University of Tokyo Hospital, 7-3-1, Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
6 shared publicationsYoshimi Higurashi
Department of Infection Control and Prevention, The University of Tokyo Hospital, Tokyo, Japan
6 shared publications
Latest Publications
- Open Access
- 21 September 2026
- Published by Elsevier in Infection Prevention in Practice
- Vol. 8 (4) , 100596
Molecular epidemiological analysis of a suspected nosocomial outbreak of carbapenem-resistant Klebsiella aerogenes
- 21 September 2026
- Published by Elsevier in Infection Prevention in Practice
- Vol. 8 (4) , 100596
Open AccessMolecular epidemiological analysis of a suspected nosocomial outbreak of carbapenem-resistant Klebsiella aerogenes
- Open Access
- 7 December 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 151, 107358
Epidemiology and risk factors for mortality in clostridial bacteremia in Japan: A retrospective multicenter observational study
- 7 December 2024
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 151, 107358
Open AccessEpidemiology and risk factors for mortality in clostridial bacteremia in Japan: A retrospective multicenter observational study
- 16 October 2024
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (2) , 102542
Carbon dioxide-dependent, extended-spectrum β-lactamase producing Escherichia coli bacteremia associated with pyelonephritis: A case-report
- 16 October 2024
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 31 (2) , 102542
Carbon dioxide-dependent, extended-spectrum β-lactamase producing Escherichia coli bacteremia associated with pyelonephritis: A case-report
- 3 September 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (11) , e31309
Management of fulminant botulism after allogeneic hematopoietic cell transplantation
- 3 September 2024
- Published by Wiley in Pediatric Blood & Cancer
- Vol. 71 (11) , e31309
Management of fulminant botulism after allogeneic hematopoietic cell transplantation
- Open Access
- 8 July 2023
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 62 (3) , 106922
Antiviral effect and safety of nafamostat mesilate in patients with mild early-onset COVID-19: An exploratory multicentre randomized controlled clinical trial
- 8 July 2023
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 62 (3) , 106922
Open AccessAntiviral effect and safety of nafamostat mesilate in patients with mild early-onset COVID-19: An exploratory multicentre randomized controlled clinical trial
- 23 April 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (8) , 1180-1181
Neisseria meningitidis serogroup W135 in a traveler visiting Japan from Argentina, 2019
- 23 April 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (8) , 1180-1181
Neisseria meningitidis serogroup W135 in a traveler visiting Japan from Argentina, 2019
- Open Access
- 5 April 2022
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-5
Aureobasidium melanigenum catheter-related bloodstream infection: a case report
Background: Aureobasidium melanigenumis a ubiquitous dematiaceous fungus that rarely causes invasive human infections. Here, we present a case ofAureobasidium melanigenumbloodstream infection in a 20-year-old man with long-term catheter use.Case presentation: A 20-year-old man receiving home care with severe disabilities due to cerebral palsy and short bowel syndrome, resulting in long-term central venous catheter use, was referred to our hospital with a fever. After the detection of yeast-like cells in blood cultures on day 3, antifungal therapy was initiated. Two identification tests performed at a clinical microbiological laboratory showed different identification results:Aureobasidium pullulansfrom matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, andCryptococcus albidusfrom a VITEK2 system. Therefore, we changed the antifungal drug to liposomal amphotericin B. The fungus was identified asA. melanigenumby DNA sequence-based analysis. The patient recovered with antifungal therapy and long-term catheter removal.Conclusion: It is difficult to correctly identifyA. melanigenumby routine microbiological testing. Clinicians must pay attention to the process of identification of yeast-like cells and retainA. melanigenumin cases of refractory fungal infection.
- 5 April 2022
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 22 (1) , 1-5
Open AccessAureobasidium melanigenum catheter-related bloodstream infection: a case report
Background: Aureobasidium melanigenumis a ubiquitous dematiaceous fungus that rarely causes invasive human infections. Here, we present a case ofAureobasidium melanigenumbloodstream infection in a 20-year-old man with long-term catheter use.Case presentation: A 20-year-old man receiving home care with severe disabilities due to cerebral palsy and short bowel syndrome, resulting in long-term central venous catheter use, was referred to our hospital with a fever. After the detection of yeast-like cells in blood cultures on day 3, antifungal therapy was initiated. Two identification tests performed at a clinical microbiological laboratory showed different identification results:Aureobasidium pullulansfrom matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, andCryptococcus albidusfrom a VITEK2 system. Therefore, we changed the antifungal drug to liposomal amphotericin B. The fungus was identified asA. melanigenumby DNA sequence-based analysis. The patient recovered with antifungal therapy and long-term catheter removal.Conclusion: It is difficult to correctly identifyA. melanigenumby routine microbiological testing. Clinicians must pay attention to the process of identification of yeast-like cells and retainA. melanigenumin cases of refractory fungal infection.
- Open Access
- 18 February 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (6) , 833-835
Human abdominal abscess caused by Necropsobacter rosorum and tips for its identification: A case report
- 18 February 2022
- Published by Elsevier in Journal of Infection and Chemotherapy
- Vol. 28 (6) , 833-835
Open AccessHuman abdominal abscess caused by Necropsobacter rosorum and tips for its identification: A case report
- Open Access
- 17 February 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 117, 302-311
Urine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries
- 17 February 2022
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 117, 302-311
Open AccessUrine sediment findings were milder in patients with COVID-19-associated renal injuries than in those with non-COVID-19-associated renal injuries